These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15168770)

  • 1. Nonalcoholic steatohepatitis with improved hepatic fibrosis after weight reduction.
    Fujikawa K; Ohata K; Honda T; Miyazoe S; Ichikawa T; Ishikawa H; Hamasaki K; Nakao K; Toriyama K; Eguchi K
    Intern Med; 2004 Apr; 43(4):289-94. PubMed ID: 15168770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycystic ovary syndrome and severe nonalcoholic steatohepatitis: beneficial effect of modest weight loss and exercise on liver biopsy findings.
    Brown AJ; Tendler DA; McMurray RG; Setji TL
    Endocr Pract; 2005; 11(5):319-24. PubMed ID: 16191492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nonalcoholic steatohepatitis--a "new" hepatic disease].
    Grønbaek H; Eivindson MV; Hamilton-Dutoit S; Vilstrup H
    Ugeskr Laeger; 2003 Mar; 165(11):1115-8. PubMed ID: 12677985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-alcoholic steatohepatitis in children.
    Nanda K
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-alcoholic steatohepatitis.
    Jansen PL
    Eur J Gastroenterol Hepatol; 2004 Nov; 16(11):1079-85. PubMed ID: 15489564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nonalcoholic steatohepatitis: diagnosis, pathogenesis, treatment and prognosis].
    Jansen PL
    Ned Tijdschr Geneeskd; 2005 Feb; 149(6):289-94. PubMed ID: 15730035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic fatty liver disease.
    Yu AS; Keeffe EB
    Rev Gastroenterol Disord; 2002; 2(1):11-9. PubMed ID: 12122975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH.
    Yoshioka Y; Hashimoto E; Yatsuji S; Kaneda H; Taniai M; Tokushige K; Shiratori K
    J Gastroenterol; 2004 Dec; 39(12):1215-8. PubMed ID: 15622489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of nonalcoholic fatty liver disease: a 60-year-old man with probable nonalcoholic fatty liver disease: weight reduction, liver biopsy, or both?
    Afdhal NH
    JAMA; 2012 Aug; 308(6):608-16. PubMed ID: 22760235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intragastric balloon significantly improves nonalcoholic fatty liver disease activity score in obese patients with nonalcoholic steatohepatitis: a pilot study.
    Lee YM; Low HC; Lim LG; Dan YY; Aung MO; Cheng CL; Wee A; Lim SG; Ho KY
    Gastrointest Endosc; 2012 Oct; 76(4):756-60. PubMed ID: 22840293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nonalcoholic steatohepatitis--current treatment options].
    Gutkowski K; Gutkowska D; Partyka M
    Przegl Lek; 2006; 63(2):91-4. PubMed ID: 16967716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [NASH -- nonalcoholic steatohepatitis].
    Blechacz B; Stremmel W
    Z Gastroenterol; 2003 Jan; 41(1):77-90. PubMed ID: 12541180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in liver histology accompanying massive weight loss after gastroplasty for morbid obesity.
    Stratopoulos C; Papakonstantinou A; Terzis I; Spiliadi C; Dimitriades G; Komesidou V; Kitsanta P; Argyrakos T; Hadjiyannakis E
    Obes Surg; 2005 Sep; 15(8):1154-60. PubMed ID: 16197789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orlistat reverse fatty infiltration and improves hepatic fibrosis in obese patients with nonalcoholic steatohepatitis (NASH).
    Hussein O; Grosovski M; Schlesinger S; Szvalb S; Assy N
    Dig Dis Sci; 2007 Oct; 52(10):2512-9. PubMed ID: 17404856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease.
    Yalamanchili K; Saadeh S; Klintmalm GB; Jennings LW; Davis GL
    Liver Transpl; 2010 Apr; 16(4):431-9. PubMed ID: 20373454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of steatohepatitis-related cirrhosis.
    Deniz K; Özcan S; Özbakır Ö; Patıroğlu TE
    Semin Liver Dis; 2015 May; 35(2):199-202. PubMed ID: 25974904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent nonalcoholic steatohepatitis and cirrhosis after liver transplantation.
    Molloy RM; Komorowski R; Varma RR
    Liver Transpl Surg; 1997 Mar; 3(2):177-8. PubMed ID: 9346733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis.
    Vilar-Gomez E; Martinez-Perez Y; Calzadilla-Bertot L; Torres-Gonzalez A; Gra-Oramas B; Gonzalez-Fabian L; Friedman SL; Diago M; Romero-Gomez M
    Gastroenterology; 2015 Aug; 149(2):367-78.e5; quiz e14-5. PubMed ID: 25865049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic steatohepatitis.
    Diehl AM
    Semin Liver Dis; 1999; 19(2):221-9. PubMed ID: 10422202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic steatohepatitis.
    Jansen PL
    Neth J Med; 2004; 62(7):217-24. PubMed ID: 15554595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.